Message from the Chief
Patient Documentary
Rock musician Pat Spurgeon recounts his battle with kidney failure and treatment by UCSF transplant surgeon Sang-Mo Kang in a recent documentary.
Transplant Video Library
View videos of lectures pertaining to transplantation given by some of the world's top experts on the subject.
Make a Gift
A gift to the Department of Surgery helps us discover new treatments and cures.
Peter G. Stock, M.D., Ph.D.
Professor of Surgery
Surgical Director, Pediatric Renal Transplantation Program
Surgical Director, Pancreas Transplant Program
Contact Information
(415) 353-1551 Clinical, Kidney and Pancreas
(415) 353-8617 Academic
stockp@surgery.ucsf.edu
Education
- University of Illinois, Urbana, IL, B.S., Biology, 1974-78
- University of Illinois, Chicago, IL, M.D., Medicine, 1978-82
- University of Minnesota, Minneapolis, MN, Ph.D., Surgery, 1985-92
Residencies
- University of Minnesota, Intern, General Surgery, 1982-83
- University of Minnesota, Resident, General Surgery, 1983-90
Fellowships
- University of California, San Francisco, Fellow, Transplant Surgery, 1990-92
Board Certification
- American Board of Surgery, 1991
Clinical Expertise
- Pancreas Transplantation
- Pancreatic Islet Cell Transplantation
- Kidney and Liver Transplantation in HIV-infected Patients
- Pediatric Renal Kidney Transplantation
Research Interests
- Beta cell replacement for the treatment of Type I diabetes mellitus
- Determining the safety and efficacy of solid organ transplantation in people with HIV
- Novel immunosuppressive regimens with co-stimulatory blockade to prevent the immune response
- Immune monitoring to assess the efficacy of immunosuppressive therapy against the alloimmune and recurrent autoimmune response
- Strategies to increase the source of beta cells
Biography
Dr. Peter Stock is Professor of Surgery and a multi-organ transplant surgeon at the University of California, San Francisco. He heads up the Solid Organ Pancreas Transplant Program as well as the Pancreatic Islet Cell Program. He is the Surgical Director of the Pediatric Renal Transplant Program. Dr. Stock is clinically active in liver, kidney and pancreas transplantation. Dr. Stock's current basic science research interests involve the induction of transplantation tolerance to block both alloimmunity as well as recurrent autoimmunity following pancreatic islet transplantation. Finally, he is the principal investigator on a study to determine the safety and efficacy of solid organ transplantation in the HIV positive recipient.
Selected Publications
- Chang GJ, Liu T, Feng S, Bedolli M, O'Rourke RW, Schmidt G, Roberts JP, Stock PG. Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts. Surgery. 132:149-56, Aug/2002.
- Roland ME, Lo B, Braff J, Stock PG. Key clinical, ethical, and policy issues in the evaluation of the safety and effectiveness of solid organ transplantation in HIV-infected patients. Arch Intern Med. 163:1773-8, 2003.
- Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, Terrault NA, Frassetto LA, Palefsky JM, Tomlanovich SJ, Ascher NL. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation. 76: 370-5, Jul/27/2003.
- Freise CE, Kang SM, Feng S, Hirose R, Stock P. Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation. Arch Surg. 138:1121-5; discussion 1125-6, Oct/2003.
- Stock PG, Bluestone JA. Beta-cell replacement for type I diabetes. Annu Rev Med. 55:133-56, 2004.
In the News
Improving the outlook for simultaneous pancreas-kidney transplants
UCSF Diabetes Center - San Francisco, CA - Feb 01, 2005"The body's rejection of transplanted organs and tissues is an unfortunate risk of transplant surgery. Historically, rejection rates in a simultaneous pancreas-kidney (SPK) transplant have been as high as 80% and, in 2001, averaged nearly 20%. ........Diabetes Center surgeons Peter Stock, (left) and Chris Freise (right) have been pioneering new methods of immunosuppression for SPK transplants that do not rely upon steroids, with great success...... "
Read Full Diabetes Center Article
Read Jourunal Article in American Journal of Transplantation
